Research in biologically active substances of the volatile fraction from Highbush blueberry vegetative organs
Keywords:Highbush blueberry, leaves, stems, fruit, chromato-mass spectrometry, terpenoids
Ukraine ranked second in the world after Peru in the pace of laying new Highbush blueberry plantations. Experts estimate that in 2018, in Ukraine, from 0.7 thousand hectares to 1.0 thousand hectares of new Highbush blueberry plantations were laid. Over the past 12 years, previously little-known product, Highbush blueberries have become one of the main berry crops. At present, commercial plantations blueberries take the 3rd place after black currants and strawberries. Zhytomyr region boasts the biggest areas planted with Highbush blueberries in Ukraine, followed by Volyn and Kyiv. According to estimates, the export of blueberries from Ukraine may increase to 20 thousand tons in 5 years.
In addition to the use of Highbush blueberries in the food industry, they are a promising source of BAS for pharmaceutical and medical use, so their study is a promising area of pharmaceutical science. In Ukraine, there are no domestic standardized medicines manufactured from Highbush blueberries, and there are only foreign dietary and functional supplements. Abroad, Highbush blueberry medicines are used to improve vision and as astringents for colitis, enterocolitis and diarrhoea. In this regard, the development of domestic standardized medicines based on Highbush blueberries raw materials is an urgent task for modern pharmacy.
The aim of the research was to study the phytochemical profile of the volatile fraction of Highbush blueberry vegetative organs (leaves, stems and fruits).
Materials and methods. The objects of research were the leaves, fruits and stems of Highbush blueberry (Vaccinium corymbosum L.), in which the composition of the the volatile fraction components was studied by chromato-mass spectrometry on a gas chromatograph Agilent Technologies 6890 with a mass spectrometric detector 5973.
Results. Chromato-mass spectrometry in the composition of volatile fractions of leaves, fruits and stems of Highbush blueberries revealed 65 substances. 49 substances were identified in the Highbush blueberry leaves, of which 36 substances of terpene nature, 13 organic acids, and 2 compounds were not identified. In the Highbush blueberries fruits, 47 substances were found, of which 36 substances are of terpene nature, 14 are organic acids and 3 were not identified. In the Highbush blueberries stems, 50 substances were found, of which 33 substances are of terpene nature, 14 are organic acids and one was not identified.
Conclusions. As a result of phytochemical studies, it is for the first time that the component composition of volatile fractions of leaves, stems and fruits of Highbush blueberries from the flora of Ukraine was established. The content of 65 substances was identified and established, including 14 organic acids and 39 terpene compounds.
Vyrashchivanie golubiki s orientatsiei na eksport [Export-oriented blueberry cultivation]. (2019, January 12). InVenture. https://inventure.com.ua/investments/vyrashivanie-golubiki
Sater, H. M., Bizzio, L. N., Tieman, D. M., & Munoz, P. D. (2020). A Review of the Fruit Volatiles Found in Blueberry and Other Vaccinium Species. Journal of Agricultural and Food Chemistry, 68(21), 5777-5786. https://doi.org/10.1021/acs.jafc.0c01445
Stefanescu, B. E., Calinoiu, L. F., Ranga, F., Fetea, F., Mocan, A., Vodnar, D. C., & Crisan, G. (2020). The Chemical and Biological Profiles of Leaves from Commercial Blueberry Varieties. Plants-Basel, 9(9), Article 1193. https://doi.org/10.3390/plants9091193
Zorzi, M., Gai, F., Medana, C., Aigotti, R., Morello, S., & Peiretti, P. G. (2020). Bioactive Compounds and Antioxidant Capacity of Small Berries. Foods, 9(5), 623. https://doi.org/10.3390/foods9050623
Hrodzinskyi, A. M. (1991). Likarski roslyny. Entsyklopedychnyi dovidnyk [Medicinal plants. Encyclopedic reference book]. Kyiv: Heads. ed. URE. [ in Ukrainian].
Fern, K. (2020). Vaccinium uliginosum. Temperate Plants Database. http://temperate.theferns.info/plant/Vaccinium+uliginosum
Mashkovskii, M. D. (2012). Lekarstvennyye sredstva [Medicines] (16th ed.). Novaya Volna. [in Russian].
Kovalenko, V. N. (Ed.). (2014). Kompendium 2014 – lekarstvennye preparaty [Compendium 2014 – medicines]. Kyiv: MORION. [in Ukrainian].
Chernykh, V. P. (Ed.). (2016). Farmatsevtychna entsyklopediia [Pharmaceutical encyclopedia]. Kyiv: MORION. [in Ukrainian].
Minarchenko, V. M., & Butko, A. Yu. (2017). Doslidzhennia vitchyznianoho rynku likarskykh zasobiv roslynnoho pokhodzhennia [Research of the domestic market of herbal medicines]. Farmatsevtychnyi zhurnal, (1), 30-36. [in Ukrainian].
Stremoukhov, A., Koshovyi, O., Kravchenko, G., Krasilnikova, O., Dimova, G., & Zhelev, I. (2021). Phytochemical and pharmacological study of the northern highbush blueberry (Vaccinium corymbosum L.) leaves dry extract. World Journal of Pharmaceutical Research, 10(4), 1-8.
State Enterprise Ukrainian Scientific Pharmacopoeial Center of Medicines Quality (2014). Derzhavna Farmakopeya Ukrayiny [The State Pharmacopoeia of Ukraine] (Vol. 1, 2nd ed.). Kharkiv: State Enterprise Ukrainian Scientific Pharmacopoeial Center of Medicines Quality. [in Ukrainian].
Koshovyi, O. M. (2012). Fenolnyi sklad deiakykh predstavnykiv pidrodu Sclarea rodu Salvia [Phenolic composition of some members of the subgenus Sclarea of the genus Salvia]. Current Issues in Pharmacy and Medicine: Science and Practice, (3), 11-14. [in Ukrainian].
Koshevoi, O. N., Vinogradov, B. A., Kovaleva, A. M., & Komissarenko, A. N. (2011). Izoprenoidnyi sostav spirtovogo ekstrakta list'ev Eucalyptus viminalis [Isoprenoid composition of the alcoholic extract of the leaves of Eucalyptus viminalis]. Current Issues in Pharmacy and Medicine: Science and Practice, 24(2), 23-35. [in Russian].
Osmachko, A., Kovaleva, A., Ilyina T., Koshovyi, O., & Sidora, N. (2017). Khromato-mas-spektrometrychne doslidzhennia nyzkomolekuliarnykh alifatychnykh, zhyrnykh ta aromatychnykh kyslot korenevyshcha Veronica teucrium L. [Chromatography-mass spectrometry study of low molecular aliphatic, fatty and aromatic acids of Veronica teucrium L. rhizomes]. ScienceRise: Pharmaceutical Science, (2), 22-25. [in Ukrainian]. https://doi.org/10.15587/2519-4852.2017.99317
Myha, M. M., Koshovyi, O. M., Hamulia, O. V., Verkhovodova, Yu. V., Kireiev, I. V., Komisarenko, A. M. (2020). Porivnialne farmakohnostychne ta farmakolohichne doslidzhennia lystia Salvia verticillata ta Salvia officinalis dlia vstanovlennia perspektyvy stvorennia novoho likarskoho zasobu [Comparative pharmacognostic and pharmacological study of Salvia verticillata and Salvia officinalis leaves to establish the prospect of creating a new medicines]. Current Issues in Pharmacy and Medicine: Science and Practice, 13(1), 61-71. [in Ukrainian]. https://doi.org/10.14739/2409-2932.2020.1.198136
Koshovyi, O., Raal, A., Kovaleva, A., Myha, M., Ilina, T., Borodina, N., & Komissarenko A. (2020). The phytochemical and chemotaxonomic study of Salvia spp. growing in Ukraine. Journal of Applied Biology & Biotechnology, 8(3), 29-36, https://doi.org/10.7324/JABB.2020.80306
How to Cite
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)